Healthy Extracts Inc. Reports Q1 2026 Financial Results: Key Insights for Investors
Summary of Key Points
- Net Loss Narrows Significantly Year-over-Year: Healthy Extracts Inc. reported a net loss of \$200,590 for the three months ended March 31, 2026, a substantial improvement from the net loss of \$398,860 in the same period in 2025.
- Increase in Shares Outstanding: The number of common shares outstanding surged to 16,890,868 as of March 31, 2026, compared to just 2,989,406 a year earlier, reflecting significant equity issuance activity.
- Stockholders’ Equity Remains Strong: Total stockholders’ equity stood at \$23,981,599 as of March 31, 2026, demonstrating solid capitalization despite ongoing losses.
- Continued Investment in Growth: The company issued common stock for services and recognized non-cash expenses for options and warrants, indicating ongoing investments in talent and business infrastructure.
- Convertible Debt Activity: No new convertible debt was issued in Q1 2026, but repayments continued, and the balance of related party notes payable increased.
Detailed Analysis
Financial Performance
For the quarter ended March 31, 2026, Healthy Extracts Inc. continued to operate at a loss, but the net loss narrowed to \$200,590 from \$398,860 in the prior year. This improvement is notable and may reflect better cost control, operational improvements, or increased revenue, though the detailed breakdown of revenue and expenses is not provided in the extracted content.
Earnings per share (EPS) on a basic and diluted basis improved markedly, with a loss per share of \$0.01 in Q1 2026 compared to a loss of \$0.13 in Q1 2025. The significant reduction in per-share loss is partly attributable to the dramatic increase in the number of shares outstanding.
Balance Sheet Highlights
- Assets: Total assets were reported at \$27,318,838 as of March 31, 2026, a slight decrease from \$27,824,664 at year-end 2025.
- Stockholders’ Equity: Stockholders’ equity remained robust at \$23,981,599, supported by a large balance of additional paid-in capital (\$43,940,618). The accumulated deficit was \$20,322,053, reflecting cumulative losses.
- Common Stock: The company has 50 million shares authorized, with 16,890,868 shares issued and outstanding as of March 31, 2026, up from 2,989,406 as of March 31, 2025. This increase was driven by equity issuances for services and likely for funding operations.
- Preferred Stock: None outstanding.
- Notes Payable: Related party notes payable increased to \$683,711 (from \$601,250 at year-end 2025), with no convertible debt outstanding at the end of the quarter.
Cash Flow and Liquidity
- Operating Activities: The company’s cash position increased modestly by \$17,450 in Q1 2026, reflecting improved operating cash flow, disciplined spending, or timely financing.
- Financing Activities: The company repaid \$106,000 in convertible debt and raised \$176,000 through new notes payable, indicating continued access to debt markets.
- Investing Activities: No significant cash flows were reported.
Equity Issuances and Dilution
The company continued to use equity as a means to compensate for services and to raise additional capital. In Q1 2026, 20,000 shares were issued for services, valued at \$38,804. The fair value of options and warrants issued during the quarter amounted to \$113,801. While these actions strengthen the company’s liquidity and align stakeholders, they also result in share dilution, which is critical for existing shareholders to consider.
Valuation and Accounting Notes
- The company uses Level 3 inputs (Black-Scholes model) for fair value estimates relating to derivative liabilities, reflecting the complexity and subjectivity involved in valuing certain financial instruments.
- No new convertible debt was issued during the quarter, and the company continues to focus on managing and extinguishing existing convertible instruments.
Potential Price-Sensitive Highlights for Shareholders
- Significant Share Dilution: The outstanding common shares increased dramatically within 12 months, which, while improving liquidity, may pressure the share price unless offset by improved operational performance.
- Reduced Losses: The narrowing of net loss and improved EPS are positive trends that may signal an improving business trajectory, potentially supporting share value if sustained.
- Ongoing Use of Equity for Compensation/Funding: Continued reliance on equity for services and funding may present both opportunities (for growth) and risks (dilution) for investors.
- No New Convertible Debt: The absence of new convertible debt issuance may be seen positively, as it limits future dilution risk and balance sheet complexity.
Conclusion
Investor Takeaway: Healthy Extracts Inc. delivered a quarter with significantly narrowed losses and a strengthened equity position, but at the cost of substantial share dilution. The company’s prudent cash management, reduction in net losses, and avoidance of new convertible debt are positive indicators. However, the surge in share count and ongoing use of equity instruments for compensation and financing are critical issues for investors to monitor, as they may impact future share value.
Disclaimer
This article is for informational purposes only and is not a recommendation to buy or sell any securities. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. The information presented is based on the company’s unaudited quarterly filings and may be subject to change or revision.
